David Rodak, MD
Cardiovascular Disease · Spartanburg, SCNPI 1215983887
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $16,389 of the $22,765 with a category attached, or 72.0%. 47 manufacturers reported payments, led by Medtronic at 37.6% of the total. Among cardiovascular disease clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 907 payments — averaging $25.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$9K
- Abbott$7K
- Boston Scientific$944
- Johnson & Johnson$672
- Novartis$669
- Inari Medical, Inc.$661
- plus $4K from 41 others
Across 500 payments — averaging $252.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biotronik Inc.$72K
- Abbott$33K
- Boston Scientific$21K
What the payments were for
- Travel & lodging$6,35928%
- Food & beverage$16,38972%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE PRECISION$1,598
- DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$779
- NA$648
- Arctic Front$540
- PulseSelect$357
- LINQ II$349
- ENSITE$318
- AFFERA MAPPING SYSTEM$280
- FLOWTRIEVER CATHETER, S$204
- WATCHMAN Access System$146
- Carto 3$137
- CardioInsight$133
- KENGREAL$132
- GENERAL - THERAPIES$129
- Assurity Pacemaker$127
- ASSURITY$124
- Watchman$123
- Barostim Neo System$121
- JOT DX$113
How this compares
$22,765 in reported general payments places this provider in the 90th percentile of 257 cardiovascular disease providers in South Carolina.
See all cardiovascular disease providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 1,134 | $1,219,780 |
| XareltoRivaroxaban | 297 | $322,353 |
| EntrestoSacubitril/Valsartan | 180 | $192,941 |
| JardianceEmpagliflozin | 105 | $98,135 |
| FarxigaDapagliflozin Propanediol | 57 | $44,107 |
| Dofetilide | 269 | $43,862 |
| Flecainide Acetate | 572 | $27,677 |
| DapagliflozinDapagliflozin Propanediol | 16 | $11,017 |
| Amiodarone Hcl | 443 | $9,937 |
| Midodrine Hcl | 109 | $8,676 |
| Metoprolol Succinate | 463 | $7,696 |
| CorlanorIvabradine Hcl | 17 | $6,958 |
| Metoprolol Tartrate | 554 | $3,909 |
| Potassium Chloride | 175 | $3,898 |
| Carvedilol | 324 | $3,517 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $122 | $1,219,7801,134 claims |
| Johnson & JohnsonXarelto | $672 | $322,353297 claims |
| NovartisEntresto | $669 | $192,941180 claims |
| Boehringer IngelheimJardiance | $26 | $98,135105 claims |
| AstraZenecaFarxiga | $111 | $44,10757 claims |
| AmgenCorlanor | $84 | $6,95817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 257 cardiovascular disease providers in South Carolina.
Other cardiovascular disease in Spartanburg
- Nalin SrivastavaSpartanburg$15K
- Alejandro LopezSpartanburg$12K
- Joseph MobleySpartanburg$10K
- Robert BiedermanCharleston$775K
- Darren SidneyNorth Charleston$129K
- Priyanka BhattacharyaCharleston$107K
- Gregory SanGreenville$88K
- David McNeelyGreenville$78K
- Gregory EavesAiken$65K
- James SmithCharleston$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.